Skip to main content
Clinical Trials/NL-OMON35991
NL-OMON35991CompletedNot Applicable

Assessment and comparison of inflammatory responses upon challenges with glucose, fat, and a combination of glucose and fat - Inflammatory responses upon challenges with glucose and/or fat

TNO0 sites14 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
14

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • 1. Healthy as assessed by:
  • a. The TNO health and lifestyle questionnaire (P9248 F02)
  • b. Results of the pre-study laboratory tests in blood
  • c. Assessment of physical characteristics
  • 2. Age 30-60 y at Day 01 of the study
  • 3. Body Mass Index (BMI) of 20 - 25 kg/m2
  • 4. Voluntary participation
  • 5. Having given written informed consent
  • 6. Willing to comply with the study procedures
  • 7. Willing to give up blood donation during the study
  • 8. Willing to accept use of all nameless data, including publication, and the confidential use and storage of all data for at least 15 years
  • 9. Willing to accept the disclosure of the financial benefit of participation in the study to the authorities concerned.

Exclusion Criteria

  • 1. Participation in any clinical trial including blood sampling and/or administration of substances up to 90 days before Day 01 of this study
  • 2. Having a history of medical or surgical events that may significantly affect the study outcome (as judged by the medical investigator)
  • 3. Having a chronic disease related to inflammation or allergy (e.g. rheumatoid arthritis, inflammatory bowel disease, asthma, eczema)
  • 4. Chronic use of medication that may affect inflammatory processes (e.g. NSAIDs, aspirin, antibiotics)
  • 5. Regular use of lipid lowering medication and/or cholesterol lowering products (e.g. Becel Pro-activ)
  • 6. Lactose intolerance or other food allergies
  • 7. Reported slimming or medically prescribed diet
  • 8. Smoking
  • 9. Alcohol consumption > 28 units/week for males and > 21 units/week for females
  • 10.Extreme physical exercise
  • 11. Recent blood donation (<1 month prior to the start of the study)
  • 12. For women: pregnant or lactating or wishing to become pregnant in the period of the study
  • 13. Personnel of TNO (location Zeist), their partner and their first and second degree relatives
  • 14. Not having a general practitioner
  • 15. Not willing to accept notification concerning participation in the study to the subject*s general practitioner
  • 16. Not willing to accept information transfer regarding health aspects, like laboratory results, findings at anamnesis or physical examination and eventual adverse events to and from the subject*s general practitioner

Investigators

Sponsor
TNO

Similar Trials

Assessment and comparison of inflammatory... | Clinical Trial